Latest filing published 14 Nov 2019 for GENOMIC HEALTH INC.
Steven Shak discloses dealings in Genomic Health Inc to SEC (Form 4). Over a trading history stretching from 15 February 2016 to 8 November 2019, the count stands at 145 filings.
Sales make up the whole of the open-market record (95 sales, €36.4M). The rest of the record consists of 8 share grants and 39 option exercises. In 2019 alone, the filings show no purchases and 60 sales.
The newest entry dates from 14 November 2019: a transaction, in Genomic Health Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 145 declarations